Nephrology and Renal Function Unit, Edouard Herriot Hospital, Hospices Civils de Lyon, Lyon, France.
Faculté de Médecine Lyon Est, Université Lyon-1 Claude Bernard, Lyon, France.
Obesity (Silver Spring). 2019 Dec;27(12):2011-2017. doi: 10.1002/oby.22574. Epub 2019 Oct 3.
Morbid obesity is associated with a higher independent risk of chronic kidney disease (CKD). Estimated glomerular filtration rate (eGFR) has been evaluated in a limited number of study participants with severe obesity.
A total of 706 measured GFR (mGFR) results from 598 participants with obesity (BMI ≥ 35 kg/m ) were retrospectively collected. The performance of the Modification of Diet in Renal Disease (MDRD) equation, Chronic Kidney Disease-Epidemiology (CKD-EPI) equation, and deindexed eGFR were compared with mGFR from the gold standard technique (inuline or iohexol), adjusted (mGFRr) or nonadjusted (mGFR) to body surface area. Absolute bias, precision, and accuracy were calculated.
Mean mGFRr (58 ± 31 mL/min/1.73 m ) was significantly different from CKD-EPI and MDRD (P < 0.001). Mean mGFR (nonindexed) (70 ± 40 mL/min) was significantly higher than mGFRr (P < 0.001). eGFR showed important biases and low accuracies for CKD-EPI and MDRD (10.7 ± 10.7 and 12.2 ± 13.7 mL/min/1.73 m ; 78% vs. 75% respectively). Deindexation worsened bias and accuracy 30% (percentage of GFR estimates within 30% of mGFRr or mGFR) between eGFR and mGFR.
eGFR overestimates mGFR and is associated with important biases and inaccuracies in patients with severe obesity, and deindexing eGFR worsens the overestimation. These findings may have important implications in examining kidney function in patients with obesity.
病态肥胖与慢性肾脏病(CKD)的独立风险增加相关。已有研究对少数严重肥胖患者的估算肾小球滤过率(eGFR)进行了评估。
回顾性收集了 598 名肥胖症患者(BMI≥35kg/m )的 706 个实测肾小球滤过率(mGFR)结果。比较了改良肾脏病饮食研究(MDRD)方程、慢性肾脏病-流行病学(CKD-EPI)方程和去指数 eGFR 与金标准技术(菊粉或碘海醇)的 mGFR 之间的性能,调整(mGFRr)或未调整(mGFR)到体表面积。计算了绝对偏差、精密度和准确性。
mGFRr(58±31ml/min/1.73m )的平均值与 CKD-EPI 和 MDRD 显著不同(P<0.001)。mGFR(未索引)(70±40ml/min)的平均值明显高于 mGFRr(P<0.001)。eGFR 对 CKD-EPI 和 MDRD 显示出重要的偏差和低准确性(10.7±10.7 和 12.2±13.7ml/min/1.73m ;分别为 78%和 75%)。去指数使 eGFR 与 mGFR 之间的偏差和准确性恶化 30%(估计肾小球滤过率在 mGFRr 或 mGFR 的 30%范围内的百分比)。
eGFR 高估了 mGFR,与严重肥胖患者的重要偏差和不准确相关,去指数 eGFR 会使高估恶化。这些发现可能对检查肥胖患者的肾功能具有重要意义。